These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 15129227)

  • 21. Hyperbilirubinemia in the 2000s: what should we do next?
    Ross G
    Am J Perinatol; 2003 Nov; 20(8):415-24. PubMed ID: 14703589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: US Preventive Services Task Force recommendation statement.
    US Preventive Services Task Force
    Pediatrics; 2009 Oct; 124(4):1172-7. PubMed ID: 19786451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refractory Causes of Kernicterus in Developed Countries: Can We Eradicate G6PD Deficiency Triggered and Low-Bilirubin Kernicterus?
    Watchko JF
    Curr Pediatr Rev; 2017; 13(3):159-168. PubMed ID: 28721814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of acute bilirubin encephalopathy and kernicterus in newborns: position statement #3049.
    NANN Board of Directors
    Adv Neonatal Care; 2011 Oct; 11(5 Suppl):S3-9. PubMed ID: 22123452
    [No Abstract]   [Full Text] [Related]  

  • 25. [Guideline 'Prevention, diagnosis and treatment of hyperbilirubinemia in the neonate with a gestational age of 35 or more weeks'].
    Dijk PH; de Vries TW; de Beer JJ;
    Ned Tijdschr Geneeskd; 2009; 153():A93. PubMed ID: 19785881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thai healthy newborns have a higher risk.
    Jirapaet K
    J Med Assoc Thai; 2005 Sep; 88(9):1314-8. PubMed ID: 16536122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004).
    Johnson L; Bhutani VK; Karp K; Sivieri EM; Shapiro SM
    J Perinatol; 2009 Feb; 29 Suppl 1():S25-45. PubMed ID: 19177057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical alterations in neonatal hyperbilirubinemia and bilirubin encephalopathy: a review.
    Karp WB
    Pediatrics; 1979 Sep; 64(3):361-8. PubMed ID: 384355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Kernicterus in a premature infant with a minimun bilirubin amount].
    Vargas Origel A; Portilla Aguilar J; Jasso Gutiérrez J
    Bol Med Hosp Infant Mex; 1977; 34(4):909-13. PubMed ID: 911446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants >or=35 weeks gestation.
    Bhutani VK; Maisels MJ; Stark AR; Buonocore G; ; ;
    Neonatology; 2008; 94(1):63-7. PubMed ID: 18204221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The jaundiced newborn. Understanding and managing transitional hyperbilirubinemia.
    Stevenson DK; Wong RJ; Hintz SR; Vreman HJ
    Minerva Pediatr; 2002 Oct; 54(5):373-82. PubMed ID: 12244276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kernicterus threatens healthy newborns.
    Jt Comm Perspect; 2001 Jun; 21(6):10-1. PubMed ID: 11424865
    [No Abstract]   [Full Text] [Related]  

  • 33. Preventing kernicterus: almost there.
    Poland RL
    J Pediatr; 2002 Apr; 140(4):385-6. PubMed ID: 12006947
    [No Abstract]   [Full Text] [Related]  

  • 34. [Contribution to the study of criteria of evaluation of the kernicterus risk in the newborn (experimental study in Gunn rats)].
    Ploussard JP; Foliot A; Christoforov B; Etienne JP; Housset E
    Arch Fr Pediatr; 1971 Oct; 28(8):797-816. PubMed ID: 5123540
    [No Abstract]   [Full Text] [Related]  

  • 35. Unbound bilirubin and risk assessment in the jaundiced newborn: possibilities and limitations.
    Hankø E
    Pediatrics; 2006 Feb; 117(2):526-7. PubMed ID: 16452374
    [No Abstract]   [Full Text] [Related]  

  • 36. The association of kernicterus with bacterial infection in the newborn.
    Pearlman MA; Gartner LM; Lee K; Eidelman AI; Morecki R; Horoupian DS
    Pediatrics; 1980 Jan; 65(1):26-9. PubMed ID: 7355031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The need for technologies to prevent bilirubin-induced neurologic dysfunction syndrome.
    Bhutani VK; Stevenson DK
    Semin Perinatol; 2011 Jun; 35(3):97-100. PubMed ID: 21641481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of kernicterus. Current methods of determining drug-induced bilirubin displacement].
    Larsen FG; Larsen CG; Brodersen R
    Ugeskr Laeger; 1983 Nov; 145(45):3473-6. PubMed ID: 6659122
    [No Abstract]   [Full Text] [Related]  

  • 39. Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: recommendation statement.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2010 Aug; 82(4):408-10. PubMed ID: 20704172
    [No Abstract]   [Full Text] [Related]  

  • 40. The Neurological Sequelae of Neonatal Hyperbilirubinemia: Definitions, Diagnosis and Treatment of the Kernicterus Spectrum Disorders (KSDs).
    Le Pichon JB; Riordan SM; Watchko J; Shapiro SM
    Curr Pediatr Rev; 2017; 13(3):199-209. PubMed ID: 28814249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.